1996

Abstract

The COVID-19 pandemic has brought considerable attention to trade in medical products, and specifically trade in products for prevention, testing and treatment. This study provides a comprehensive overview of trade and tariffs imposed on medical goods in general, many of which appear to be in severe shortage as a result of the current crisis. The purpose of this note is to provide factual information on how these goods are traded globally.

Loading

Article metrics loading...

/content/papers/27095819/1
2020-04-03
2024-04-18
http://instance.metastore.ingenta.com/content/papers/27095819/1
Loading
  • Published online: 03 Apr 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
aHR0cHM6Ly93d3cud3RvLWlsaWJyYXJ5Lm9yZy8K